A team led by the University of Bristol in collaboration with UEA, Oxford and Exeter studied 409,000 patients who had hip replacements for osteoarthritis between 2003 and 2011.
They analysed data on death after hip replacement on behalf of the National Joint Registry for England, Wales and Northern Ireland (NJR). The results are published today in The Lancet.
The study found:
– Between 2003 and 2011 mortality rates in the first 90 days following surgery halved from 0.6 per cent to 0.3 per cent.
– Four simple treatment options are associated with lower death rates. These are: the use of spinal anaesthetic, the posterior surgical approach, the use of chemical thromboprophylaxis with heparin and the use of mechanical thromboprophylaxis.
– Overweight patients with a body mass index between 25 and 30 kg/m2 have a lower risk of death than those with a “normal” body mass index of 20-25 kg/m2.
– Patients with certain medical conditions are at a much higher risk of death in the 90 days following surgery. Severe liver disease is associated with a ten-fold increase, a previous heart attack is associated with a three-fold increase and both diabetes and renal disease are associated with a two-fold increase.
Musculoskeletal epidemiologist Prof Alex MacGregor from UEA’s Norwich Medical School has helped shape the development of the National Joint Registry since its inception in 2003.
He said: “The registry records all elective hip, knee, ankle, and shoulder replacement operations in England and Wales – and with over 1.4 million records it is the largest registry of its type in the world. In this study, I contributed to analytical work on mortality rates among patients undergoing hip joint replacements led by Prof Ashely Blom in Bristol.”
Prof Blom said: “It is extremely good news that the risk of death after hip replacements has reduced so dramatically in England and Wales. It is also very exciting that we can further reduce the risk of post-operative death by adopting four relatively simple measures.
“The finding that overweight people have a lower risk of death is surprising, but has been confirmed by other recent studies, and challenges some of our preconceptions. We need to concentrate efforts on reducing the risk of death in high risk groups such as those with severe liver disease.”
’90-day mortality after 409 096 total hip replacements for osteoarthritis, from the National Joint Registry for England and Wales: a retrospective analysis’ by Linda P Hunt, Yoav Ben-Shlomo, Emma M Clark, Paul Dieppe, Andrew Judge, Alex J MacGregor, Jon H Tobias, Kelly Vernon, and Ashley W Blom, on behalf of the National Joint Registry for England, Wales and Northern Ireland is published in The Lancet 2013; Vol 382: 1097–104, on September 28, 2013.
University of East Anglia – Communications Office
Tel: (+44) (0) 1603 593496 Fax: (+44) (0) 1603 259883